HelixNano
Biotechnology ResearchMassachusetts, United States11-50 Employees
HelixNano is building the world's most advanced mRNA platform to enable previously impossible applications across human and non-human biology
Insights
Innovative mRNA Platform HelixNano is developing an advanced mRNA platform capable of creating multi-antigen vaccines that can target SARS-CoV-2 and its mutations, indicating strong potential for collaborations in infectious disease therapeutics and vaccine development.
Strategic Partnerships The company's recent integration with Medicus Pharma to develop thermostable infectious disease vaccines presents opportunities to expand sales through joint product offerings and licensing agreements.
Market Positioning As a biotech specializing in cutting-edge mRNA technology with a revenue range of 10 to 25 million USD, HelixNano offers a unique entry point for pharmaceutical companies seeking innovative vaccine solutions in a competitive biotech landscape.
Funding and Growth Potential While specific funding data is unavailable, HelixNano’s collaborations and vaccine development initiatives suggest significant growth opportunities, which could attract partners interested in scaling mRNA-based therapeutics.
Targeted Vaccine Development With a focus on thermostable vaccines and mutation-resistant formulations, HelixNano’s offerings are well-positioned to appeal to public health agencies and global markets seeking durable, adaptable vaccination platforms.
HelixNano Tech Stack
HelixNano uses 8 technology products and services including WordPress, Squarespace, Google Workspace, and more. Explore HelixNano's tech stack below.
- WordPressContent Management System
- SquarespaceContent Management System
- Google WorkspaceEmail
- TwemojiFont Scripts
- Google Fonts APIFont Scripts
- PHPProgramming Languages
- GoDaddyWeb Hosting
- prettyPhotoWeb Tools And Plugins
Media & News
HelixNano's Email Address Formats
HelixNano uses at least 1 format(s):
| HelixNano Email Formats | Percentage |
| First@helixnano.com | 100% |
Frequently Asked Questions
Where is HelixNano's headquarters located?
HelixNano's main headquarters is located at 700 Main Street Cambridge, Massachusetts 02139 United States. The company has employees across 1 continents, including North America. What is HelixNano's official website and social media links?
HelixNano's official website is helixnano.com and has social profiles on LinkedInCrunchbase.What is HelixNano's SIC code NAICS code?
HelixNano's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does HelixNano have currently?
As of April 2026, HelixNano has approximately 20 employees across 1 continents, including North America. Key team members include Chief Scientific Officer: M. K.Chief Operating Officer: J. C.Director, Cmc Strategy: N. K.. Explore HelixNano's employee directory with LeadIQ.What technology does HelixNano use?
HelixNano's tech stack includes WordPressSquarespaceGoogle WorkspaceTwemojiGoogle Fonts APIPHPGoDaddyprettyPhoto. What is HelixNano's email format?
HelixNano's email format typically follows the pattern of First@helixnano.com. Find more HelixNano email formats with LeadIQ. When was HelixNano founded?
HelixNano was founded in 2013.
Company Overview
- Headquarters
- 700 Main Street Cambridge, Massachusetts 02139 United States
- Website
- helixnano.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2013
- Employees
- 11-50
Funding & Financials
- $10M$25M
HelixNano's revenue is estimated to be in the range of $10M$25M
Funding & Financials
- $10M$25M
HelixNano's revenue is estimated to be in the range of $10M$25M
Company Leadership
M. K.Chief Scientific Officer- J. C.Chief Operating Officer
- N. K.Director, Cmc Strategy
- N. E.Board Member
K. J.Cell Therapy Scientist
Employee Directory
H. A.Cell Whisperer- A. L. S.Mrna Explorer Scientist
- D. D.Research Scientist - Immune/In Vivo Inquirer
- D. D. J. D. P.Research Scientist - Immune And In Vivo Inquirer
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
